Skip to main content
. 2008 Jun 10;22(6):629–640. doi: 10.1007/s10278-008-9128-x

Table 3.

Clinical Indications with Low FPOS Rates

Clinical indications FPOS rates
Lymphoma 60.7% (632/1,042)
Pituitary gland dysfunction 60.8% (379/623)
Chronic headache 64.0% (429/670)
Dizziness 70.9% (1,579/2,227)
Hypertension 71.2% (1,300/1,826)
Sensation loss 72.0% (542/753)
Vision changes 73.8% (807/1,093)
Coronary artery disease 74.3% (609/820)
Dyspnea on exertion 75.2% (1,473/1,958)
Lymphadenopathy 79.1% (1,048/1,325)